B. Scott Segal to Myeloid Cells
This is a "connection" page, showing publications B. Scott Segal has written about Myeloid Cells.
Connection Strength
1.339
-
Giles DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, Ponath G, Pitt D, Segal BM. Myeloid cell plasticity in the evolution of central nervous system autoimmunity. Ann Neurol. 2018 01; 83(1):131-141.
Score: 0.593
-
Godoy HE, Khan AN, Vethanayagam RR, Grimm MJ, Singel KL, Kolomeyevskaya N, Sexton KJ, Parameswaran A, Abrams SI, Odunsi K, Segal BH. Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice. PLoS One. 2013; 8(7):e69631.
Score: 0.435
-
Stoolman JS, Duncker PC, Huber AK, Giles DA, Washnock-Schmid JM, Soulika AM, Segal BM. An IFN?/CXCL2 regulatory pathway determines lesion localization during EAE. J Neuroinflammation. 2018 Jul 16; 15(1):208.
Score: 0.154
-
Rumble JM, Huber AK, Krishnamoorthy G, Srinivasan A, Giles DA, Zhang X, Wang L, Segal BM. Neutrophil-related factors as biomarkers in EAE and MS. J Exp Med. 2015 Jan 12; 212(1):23-35.
Score: 0.120
-
Neal LM, Xing E, Xu J, Kolbe JL, Osterholzer JJ, Segal BM, Williamson PR, Olszewski MA. CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. mBio. 2017 11 21; 8(6).
Score: 0.037